1. Home
  2. FLYX vs NMRA Comparison

FLYX vs NMRA Comparison

Compare FLYX & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLYX
  • NMRA
  • Stock Information
  • Founded
  • FLYX 2015
  • NMRA 2019
  • Country
  • FLYX United States
  • NMRA United States
  • Employees
  • FLYX N/A
  • NMRA N/A
  • Industry
  • FLYX Blank Checks
  • NMRA
  • Sector
  • FLYX Finance
  • NMRA
  • Exchange
  • FLYX Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • FLYX 264.1M
  • NMRA 287.6M
  • IPO Year
  • FLYX N/A
  • NMRA 2023
  • Fundamental
  • Price
  • FLYX $3.19
  • NMRA $1.03
  • Analyst Decision
  • FLYX
  • NMRA Buy
  • Analyst Count
  • FLYX 0
  • NMRA 8
  • Target Price
  • FLYX N/A
  • NMRA $10.14
  • AVG Volume (30 Days)
  • FLYX 11.9K
  • NMRA 1.3M
  • Earning Date
  • FLYX 01-01-0001
  • NMRA 03-03-2025
  • Dividend Yield
  • FLYX N/A
  • NMRA N/A
  • EPS Growth
  • FLYX N/A
  • NMRA N/A
  • EPS
  • FLYX N/A
  • NMRA N/A
  • Revenue
  • FLYX $327,274,000.00
  • NMRA N/A
  • Revenue This Year
  • FLYX $4.63
  • NMRA N/A
  • Revenue Next Year
  • FLYX $33.97
  • NMRA N/A
  • P/E Ratio
  • FLYX N/A
  • NMRA N/A
  • Revenue Growth
  • FLYX 3.78
  • NMRA N/A
  • 52 Week Low
  • FLYX $1.79
  • NMRA $1.02
  • 52 Week High
  • FLYX $8.39
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • FLYX 48.68
  • NMRA 26.42
  • Support Level
  • FLYX $3.01
  • NMRA $1.12
  • Resistance Level
  • FLYX $3.53
  • NMRA $1.23
  • Average True Range (ATR)
  • FLYX 0.27
  • NMRA 0.10
  • MACD
  • FLYX -0.00
  • NMRA 0.04
  • Stochastic Oscillator
  • FLYX 35.38
  • NMRA 2.18

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Share on Social Networks: